Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have ovaries
- People who have undergone genetic testing and do not carry any of the gene mutations listed in the exclusion criteria below
Who may not be able to join:
- People who carry certain genetic mutations known to increase the risk of ovarian cancer, including BRCA1, BRCA2, BRIP1, PALB2, ATM, or those associated with Lynch Syndrome (MLH1, MSH2/EPCAM, MSH6)
- People who have not had genetic testing done, or whose genetic status is unknown
- People who have previously been diagnosed with cancer
- People who have previously received any cancer treatment
- People who are currently using hormone replacement therapy (HRT)
- People who have used antibiotics in the month before providing a sample for the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Susan Domchek, MD, University of Pennsylvania
Phone: 215-360-0422
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Microbiome Involvement; Predictive Model
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.